Patients with polyclonal hepatocellular carcinoma are at a high risk of early recurrence and have a poor recurrence-free survival period.
Masaki KaiboriKazuko SakaiHideyuki MatsushimaHisashi KosakaKosuke MatsuiMarco A De VelascoMitsugu SekimotoKazuto NishioPublished in: Hepatology international (2022)
CC is a possible candidate biomarker for predicting the risk of early postoperative recurrence and warrants further investigation.
Keyphrases